눈 건강 성분 시장 규모 : 성분, 형태, 적응 질환, 공급원, 최종 용도별, 예측(2023-2032년)

Eye Health Ingredients Market Size - By Ingredient, Form, Disease Indication, Source, End Use & Forecast, 2023 - 2032

US $ 4,850 ￦ 7,017,000

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,050 ￦ 8,753,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,350 ￦ 12,081,000

PDF & Excel (Enterprise User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

눈 건강 성분 시장은 소비자 의식의 향상, 성분 배합의 혁신, 안질환의 이환율 상승을 배경으로 2023-2032년 CAGR 7.5%를 기록할 것으로 예상되고 있습니다.

세계보건기구(WHO)가 2023년 발표한 보고서에 따르면 세계 22억 명 이상이 근거리 또는 원거리 시력 장애를 경험하고 있으며, 예방이 가능하거나 치료되지 않은 사례는 최소 10억 명 이상에 영향을 미치고 있습니다. 안구 건강에 대한 관심이 높아짐에 따라 안구 건강을 증진하고 유지하는 데 있으며, 표적 성분이 얼마나 중요한 역할을 하는지에 대한 인식과 인식이 높아지고 있습니다. 또한 특정 안구 건강 문제를 해결하기 위한 솔루션에 대한 절실한 요구가 제품 수요를 더욱 증가시키고 있습니다.

베타카로틴 성분 부문은 항산화 특성과 체내에서 비타민 A를 전환하는 능력으로 인해 건강한 시력을 촉진하기 때문에 2032년까지 상당한 수요가 예상됩니다. 또한 베타카로틴은 레티놀의 필수 전구체로서 안구 조직 유지와 노화성 황반변성 예방에 기여합니다.

동물용 최종 용도 부문은 반려동물의 건강과 시력 유지에 있으며, 영양의 중요한 역할에 대한 인식이 높아짐에 따라 2032년까지 강력한 성장세를 보일 것으로 예상됩니다. 반려동물의 눈 건강 성분을 반려동물사료 및 보충제에 원활하게 통합함으로써 반려동물의 진화하는 요구에 부응하는 특수 제품들이 급증할 것으로 예상됩니다. 또한 눈 건강을 포함한 반려동물의 전반적인 건강에 대한 소비자의 인식이 높아짐에 따라 제품 수요를 촉진할 것으로 예상됩니다.

북미 눈 건강 성분 산업 점유율은 2023-2032년 사이에 건강 지향적인 소비자층, 첨단화된 의료 인프라, 예방적 헬스케어의 채택 증가로 인해 빠르게 성장할 것으로 예상됩니다. 북미 소비자들은 눈 건강을 우선시하고 건강기능식품을 받아들이고 있으며, 이 지역 시장은 더욱 확대될 것으로 보입니다.

목차

제1장 조사 방법과 조사 범위

제2장 주요 요약

제3장 눈 건강 성분 업계 인사이트

• 산업 세분화
• 업계 성장 상황, 2018-2032년
• 에코시스템 분석
  • 지역별 이익률 동향
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 벤더 매트릭스
    • 원료 공급업체
    • 원료 제조업체
    • 지역적 발자국
    • 주요 제조업체의 생산능력
  • 유통 채널 분석
    • 슈퍼마켓
    • 전문 소매
    • 약국 체인
    • 독립계 소매업체
    • 인터넷/홈쇼핑
• 지역별 가격 동향
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 무역 시나리오
• 규제 상황
  • 착색료 첨가제 규제
    • 미국
    • 유럽
    • 중국
    • 아시아태평양
• 지역별 원료 동향
  • 루테인
  • 제아크산틴
  • 베타 카로틴
  • 비타민 A
  • 빌베리 엑기스
  • 기타(캡산틴, 아나토, 오메가 3)
• 업계에 대한 영향요인
  • 촉진요인
    • 눈 건강에 대한 소비자 관심의 증가
    • 뉴트라슈티컬 산업의 확대
    • 고령자 인구에서 AMD 질환 발생의 증가
    • 의료 지출의 증가에 의한 OTC 보충제에 대한 소비자 관심의 증가
  • 업계의 잠재적 리스크·과제
    • 루테인과 제아크산틴의 가용성 제한
    • 카로티노이드 섭취에 의한 건강에 대한 악영향
• 눈 건강 성분의 최신 제품 발표
  • 미국
  • 독일
  • 러시아
  • 인도
  • 영국
  • 중국
  • 브라질
  • 남아프리카공화국
• 성장 가능성 분석, 2022년
• 중요한 성공요인
  • 업계단체의 역할
  • 시력 저하 국제인구 통계
  • 눈 건강 성분에 대한 소비자 행동
  • OTC 아이케어 보충제와 처방된 아이케어 보충제의 비교
  • 지역별 소비자 인사이트
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
• Porter의 산업 분석
• 기업 점유율 분석, 2022년
  • 전략 대시보드
• PESTEL 분석

제4장 눈 건강 성분 시장 : 공급원별

• 세계의 눈 건강 성분 시장 : 공급원별 점유율, 2018년·2032년
• 천연
• 합성

제5장 눈 건강 성분 시장 : 성분별

• 세계의 눈 건강 성분 시장 : 성분별 점유율, 2018년·2032년
• 루테인
• 제아크산틴
• 베타 카로틴
• 비타민 A
• 빌베리 엑기스
• 기타(비타민 C, 비타민 E, 아연 & 오메가 3 지방산, 아스타잔틴)

제6장 눈 건강 성분 시장 : 형태별

• 세계의 눈 건강 성분 시장 : 형태별 점유율, 2018년·2032년
• 소프트젤, 캡슐, 정제
• 액체
• 분말

제7장 눈 건강 성분 시장 : 용도별

• 세계의 눈 건강 성분 시장 : 용도별 점유율, 2018년·2032년
• 인간
• 동물

제8장 눈 건강 성분 시장 : 적응 질환별

• 세계의 눈 건강 성분 시장 : 적응 질환별 점유율, 2018년·2032년
• 노인황반변성
• 백내장
• 안구건조증
• 기타 적응증

제9장 눈 건강 성분 시장 : 지역별

• 세계의 눈 건강 성분 시장 : 지역별 점유율, 2018년·2032년
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 러시아
• 아시아태평양
  • 중국
  • 인도
  • 한국
  • 일본
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 기업 개요

• Allied Biotech Corporation
• BASF
• DSM
• Kemin
• Tianjin Pharmaland Technology
• American River Nutrition, Inc
• Archer Daniels Midland Company
• Vitae Naturals
• Davos life Science
• Cargil
• Wilmer Spring Fruit Nutrition Products Co. Ltd
• FMC corporation
• Vidya Europe SAS

제11장 잠재 고객의 개요

• Amway
• Solgar
• Life extension
• Jarrow Formulas
• NOW Foods
• Natures's Life
• Nutrovea
• Natures Lab
• Zenith Nutrition
• Blubonnet Nutrition
• Sirulina
• Caps Extra
• MacuShield
• PreserVision
• Efalex
• BioCare NutriGuard
• Futurebiotics
• Swanson Products
• Davis Vision
• Alcon
• Pfizer Inc.
• Vitabiotics Ltd.
• Valeant Pharmaceuticals International Inc.
• Alliance Pharma
• The Nature's Bounty Co
• Novartis AG

KSA

영문 목차

영문목차

Eye Health Ingredients Market is expected to register a 7.5% CAGR during 2023-2032, driven by rising consumer awareness, innovations in ingredient formulations, and rising incidence of eye conditions.

According to a report published by WHO in 2023, globally, over 2.2 billion people experience either near or distance vision impairment, with preventable or unaddressed cases affecting at least 1 billion individuals. As more individuals grapple with eye health issues, there is a growing awareness and recognition of the pivotal role that targeted ingredients play in promoting and maintaining ocular well-being. Moreover, the imperative need for solutions tailored to address specific eye health issues has further propelled the product demand.

The overall eye health ingredients industry is classified based on source, ingredient, end-use, form disease indication and region.

Beta carotene ingredient segment is anticipated to witness substantial demand through 2032 fuelled by its antioxidant properties and the ability to convert vitamin A in the body thereby promoting healthy vision. Moreover, as an essential precursor to retinol, beta carotene contributes to the maintenance of eye tissues and the prevention of age-related macular degeneration.

The animal end-use segment is poised for robust growth through 2032, driven by the growing recognition of pet health and the pivotal role of nutrition in sustaining their vision. The seamless integration of eye health ingredients into pet foods and supplements is anticipated to fuel a surge in specialized products, catering to the evolving needs of companion animals. Additionally, the rise of consumer awareness about the overall well-being of pets, including eye health, is expected to propel the product demand.

North America eye health ingredients industry share is expected to register swift gains during 2023-2032 driven by the region's health-conscious consumer base, advanced healthcare infrastructure, and increasing adoption of preventive health measures. As consumers in North America prioritize eye health and embrace nutritional supplements, the regional market will further expand.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
  • 1.1.1 Initial data exploration
  • 1.1.2 Statistical model and forecast
  • 1.1.3 Industry insights and validation
  • 1.1.4 Definitions & forecast parameters
• 1.2 Data sources
  • 1.2.1 Secondary
  • 1.2.2 Primary

Chapter 2 Executive Summary

• 2.1 Eye health ingredients market 360 degree synopsis, 2018 -2032
  • 2.1.1 Business trends
  • 2.1.2 Source trends
  • 2.1.3 Ingredient trends
  • 2.1.4 Form trends
  • 2.1.5 Application trends
  • 2.1.6 Disease indication trends
  • 2.1.7 Regional trends

Chapter 3 Eye Health Ingredients Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry growth landscape, 2018 -2032
• 3.3 Industry ecosystem analysis
  • 3.3.1 Regional profit margin trends
    • 3.3.1.1 North America
    • 3.3.1.2 Europe
    • 3.3.1.3 APAC
    • 3.3.1.4 LATAM
    • 3.3.1.5 MEA
  • 3.3.2 Vendor matrix
    • 3.3.2.1 Raw material suppliers
    • 3.3.2.2 Ingredient manufacturers
    • 3.3.2.3 Geographical footprint
    • 3.3.2.4 Production capacity of key players
  • 3.3.3 Distribution channel analysis
    • 3.3.3.1 Supermarkets
    • 3.3.3.2 Specialty retail
    • 3.3.3.3 Pharmacy Chains
    • 3.3.3.4 Independent Retailers
    • 3.3.3.5 Internet/ home shopping
• 3.4 Regional pricing trends
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 APAC
  • 3.4.4 LATAM
  • 3.4.5 MEA
• 3.5 Trade scenario
• 3.6 Regulatory landscape
  • 3.6.1 Regulation of Color Additives
    • 3.6.1.1 U.S.
    • 3.6.1.2 Europe
    • 3.6.1.3 China
    • 3.6.1.4 APAC
• 3.7 Regional raw material trends
  • 3.7.1 Lutein
  • 3.7.2 Zeaxanthin
  • 3.7.3 Beta Carotene
  • 3.7.4 Vitamin A
  • 3.7.5 Bilberry extracts
  • 3.7.6 Others (Capsanthin, Annatto, Omega-3)
• 3.8 Industry impact forces
  • 3.8.1 Growth drivers
    • 3.8.1.1 Increasing consumer concerns around eye health
    • 3.8.1.2 Nutraceutical industry expansion
    • 3.8.1.3 Increasing AMD disease occurrence among geriatric population
    • 3.8.1.4 Increase in healthcare expenditure leading consumer interest over OTC supplements
  • 3.8.2 Industry pitfalls & challenges
    • 3.8.2.1 Limited availability of lutein and zeaxanthin
    • 3.8.2.2 Harmful health effects from carotenoid consumption
• 3.9 Eye health ingredients latest product launches
  • 3.9.1 U.S.
  • 3.9.2 Germany
  • 3.9.3 Russia
  • 3.9.4 India
  • 3.9.5 UK
  • 3.9.6 China
  • 3.9.7 Brazil
  • 3.9.8 South Africa
• 3.10 Growth potential analysis, 2022
• 3.11 Critical success factors
  • 3.11.1 Role of industry associations
  • 3.11.2 International demographics of declining vision
  • 3.11.3 Consumer behavior towards eye health ingredients
  • 3.11.4 OTC eye care supplements vs prescribed eyecare supplements
  • 3.11.5 Regional consumer insights
    • 3.11.5.1 North America
    • 3.11.5.2 Europe
    • 3.11.5.3 APAC
    • 3.11.5.4 LATAM
    • 3.11.5.5 MEA
• 3.12 Porter's analysis
• 3.13 Company market share analysis, 2022
  • 3.13.1 Strategy dashboard
• 3.14 PESTEL analysis

Chapter 4 Eye Health Ingredients Market, By Source

• 4.1 Global eye health ingredients market share by source, 2018 & 2032
• 4.2 Natural
  • 4.2.1 Market estimates and forecast, 2018 -2032
  • 4.2.2 Market estimates and forecast, by region, 2018-2032
• 4.3 Synthetic
  • 4.3.1 Market estimates and forecast, 2018 -2032
  • 4.3.2 Market estimates and forecast, by region, 2018-2032

Chapter 5 Eye Health Ingredients Market, By Ingredient

• 5.1 Global eye health ingredients market share by ingredient, 2018 & 2032
• 5.2 Lutein
  • 5.2.1 Market estimates and forecast, 2018 -2032
  • 5.2.2 Market estimates and forecast, by region, 2018-2032
• 5.3 Zeaxanthin
  • 5.3.1 Market estimates and forecast, 2018 -2032
  • 5.3.2 Market estimates and forecast, by region, 2018-2032
• 5.4 Beta Carotene
  • 5.4.1 Market estimates and forecast, 2018 -2032
  • 5.4.2 Market estimates and forecast, by region, 2018-2032
• 5.5 Vitamin A
  • 5.5.1 Market estimates and forecast, 2018 -2032
  • 5.5.2 Market estimates and forecast, by region, 2018-2032
• 5.6 Bilberry extracts
  • 5.6.1 Market estimates and forecast, 2018 -2032
  • 5.6.2 Market estimates and forecast, by region, 2018-2032
• 5.7 Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)
  • 5.7.1 Market estimates and forecast, 2018 -2032
  • 5.7.2 Market estimates and forecast, by region, 2018-2032

Chapter 6 Eye Health Ingredients Market, By Form

• 6.1 Global eye health ingredients market share by form, 2018 & 2032
• 6.2 Soft gel, capsule & tablets
  • 6.2.1 Market estimates and forecast, 2018 -2032
  • 6.2.2 Market estimates and forecast, by region, 2018-2032
• 6.3 Liquid
  • 6.3.1 Market estimates and forecast, 2018 -2032
  • 6.3.2 Market estimates and forecast, by region, 2018-2032
• 6.4 Powder
  • 6.4.1 Market estimates and forecast, 2018 -2032
  • 6.4.2 Market estimates and forecast, by region, 2018-2032

Chapter 7 Eye Health Ingredients Market, By Application

• 7.1 Global eye health ingredients market share by application, 2018 & 2032
• 7.2 Human
  • 7.2.1 Market estimates and forecast, 2018 -2032
  • 7.2.2 Market estimates and forecast, by region, 2018-2032
• 7.3 Animal
  • 7.3.1 Market estimates and forecast, 2018 -2032
  • 7.3.2 Market estimates and forecast, by region, 2018-2032

Chapter 8 Eye Health Ingredients Market, By Disease Indication

• 8.1 Global eye health ingredients market share by disease indication, 2018 & 2032
• 8.2 Age related macular degeneration
  • 8.2.1 Market estimates and forecast, 2018 -2032
  • 8.2.2 Market estimates and forecast, by region, 2018-2032
• 8.3 Cataract
  • 8.3.1 Market estimates and forecast, 2018 -2032
  • 8.3.2 Market estimates and forecast, by region, 2018-2032
• 8.4 Dry eye syndrome
  • 8.4.1 Market estimates and forecast, 2018 -2032
  • 8.4.2 Market estimates and forecast, by region, 2018-2032
• 8.5 Other indications
  • 8.5.1 Market estimates and forecast, 2018 -2032
  • 8.5.2 Market estimates and forecast, by region, 2018-2032

Chapter 9 Eye Health Ingredients Market, By Region

• 9.1 Global eye health ingredients market share by region, 2018 & 2032
• 9.2 North America
  • 9.2.1 Market estimates and forecast, 2018 - 2032
  • 9.2.2 Market estimates and forecast, by source, 2018 - 2032
  • 9.2.3 Market estimates and forecast, by ingredient, 2018 - 2032
  • 9.2.4 Market estimates and forecast, by form, 2018 - 2032
  • 9.2.5 Market estimates and forecast, by application, 2018 - 2032
  • 9.2.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.2.7 U.S.
    • 9.2.7.1 Market estimates and forecast, 2018 - 2032
    • 9.2.7.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.2.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.2.7.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.2.7.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.2.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.2.8 Canada
    • 9.2.8.1 Market estimates and forecast, 2018 - 2032
    • 9.2.8.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.2.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.2.8.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.2.8.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.2.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
• 9.3 Europe
  • 9.3.1 Market estimates and forecast, 2018 - 2032
  • 9.3.2 Market estimates and forecast, by source, 2018 - 2032
  • 9.3.3 Market estimates and forecast, by ingredient, 2018 - 2032
  • 9.3.4 Market estimates and forecast, by form, 2018 - 2032
  • 9.3.5 Market estimates and forecast, by application, 2018 - 2032
  • 9.3.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.3.7 Germany
    • 9.3.7.1 Market estimates and forecast, 2018 - 2032
    • 9.3.7.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.3.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.3.7.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.3.7.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.3.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.3.8 UK
    • 9.3.8.1 Market estimates and forecast, 2018 - 2032
    • 9.3.8.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.3.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.3.8.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.3.8.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.3.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.3.9 France
    • 9.3.9.1 Market estimates and forecast, 2018 - 2032
    • 9.3.9.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.3.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.3.9.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.3.9.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.3.9.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.3.10 Italy
    • 9.3.10.1 Market estimates and forecast, 2018 - 2032
    • 9.3.10.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.3.10.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.3.10.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.3.10.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.3.10.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.3.11 Russia
    • 9.3.11.1 Market estimates and forecast, 2018 - 2032
    • 9.3.11.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.3.11.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.3.11.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.3.11.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.3.11.6 Market estimates and forecast, by disease indication, 2018 - 2032
• 9.4 Asia Pacific
  • 9.4.1 Market estimates and forecast, 2018 - 2032
  • 9.4.2 Market estimates and forecast, by source, 2018 - 2032
  • 9.4.3 Market estimates and forecast, by ingredient, 2018 - 2032
  • 9.4.4 Market estimates and forecast, by form, 2018 - 2032
  • 9.4.5 Market estimates and forecast, by application, 2018 - 2032
  • 9.4.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.4.7 China
    • 9.4.7.1 Market estimates and forecast, 2018 - 2032
    • 9.4.7.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.4.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.4.7.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.4.7.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.4.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.4.8 India
    • 9.4.8.1 Market estimates and forecast, 2018 - 2032
    • 9.4.8.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.4.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.4.8.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.4.8.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.4.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.4.9 South Korea
    • 9.4.9.1 Market estimates and forecast, 2018 - 2032
    • 9.4.9.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.4.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.4.9.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.4.9.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.4.9.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.4.10 Japan
    • 9.4.10.1 Market estimates and forecast, 2018 - 2032
    • 9.4.10.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.4.10.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.4.10.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.4.10.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.4.10.6 Market estimates and forecast, by disease indication, 2018 - 2032
• 9.5 Latin America
  • 9.5.1 Market estimates and forecast, 2018 - 2032
  • 9.5.2 Market estimates and forecast, by source, 2018 - 2032
  • 9.5.3 Market estimates and forecast, by ingredient, 2018 - 2032
  • 9.5.4 Market estimates and forecast, by form, 2018 - 2032
  • 9.5.5 Market estimates and forecast, by application, 2018 - 2032
  • 9.5.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.5.7 Brazil
    • 9.5.7.1 Market estimates and forecast, 2018 - 2032
    • 9.5.7.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.5.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.5.7.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.5.7.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.5.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.5.8 Mexico
    • 9.5.8.1 Market estimates and forecast, 2018 - 2032
    • 9.5.8.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.5.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.5.8.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.5.8.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.5.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.5.9 Argentina
    • 9.5.9.1 Market estimates and forecast, 2018 - 2032
    • 9.5.9.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.5.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.5.9.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.5.9.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.5.9.6 Market estimates and forecast, by disease indication, 2018 - 2032
• 9.6 Middle East & Africa (MEA)
  • 9.6.1 Market estimates and forecast, 2018 - 2032
  • 9.6.2 Market estimates and forecast, by source, 2018 - 2032
  • 9.6.3 Market estimates and forecast, by ingredient, 2018 - 2032
  • 9.6.4 Market estimates and forecast, by form, 2018 - 2032
  • 9.6.5 Market estimates and forecast, by application, 2018 - 2032
  • 9.6.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.6.7 Saudi Arabia
    • 9.6.7.1 Market estimates and forecast, 2018 - 2032
    • 9.6.7.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.6.7.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.6.7.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.6.7.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.6.7.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.6.8 UAE
    • 9.6.8.1 Market estimates and forecast, 2018 - 2032
    • 9.6.8.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.6.8.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.6.8.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.6.8.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.6.8.6 Market estimates and forecast, by disease indication, 2018 - 2032
  • 9.6.9 South Africa
    • 9.6.9.1 Market estimates and forecast, 2018 - 2032
    • 9.6.9.2 Market estimates and forecast, by source, 2018 - 2032
    • 9.6.9.3 Market estimates and forecast, by ingredient, 2018 - 2032
    • 9.6.9.4 Market estimates and forecast, by form, 2018 - 2032
    • 9.6.9.5 Market estimates and forecast, by application, 2018 - 2032
    • 9.6.9.6 Market estimates and forecast, by disease indication, 2018 - 2032

Chapter 10 Company Profiles

• 10.1 Allied Biotech Corporation
  • 10.1.1 Business Overview
  • 10.1.2 Financial Data
  • 10.1.3 Concentrations Landscape
  • 10.1.4 Strategic Outlook
  • 10.1.5 SWOT Analysis
• 10.2 BASF
  • 10.2.1 Business Overview
  • 10.2.2 Financial Data
  • 10.2.3 Concentrations Landscape
  • 10.2.4 Strategic Outlook
  • 10.2.5 SWOT Analysis
• 10.3 DSM
  • 10.3.1 Business Overview
  • 10.3.2 Financial Data
  • 10.3.3 Concentrations Landscape
  • 10.3.4 Strategic Outlook
  • 10.3.5 SWOT Analysis
• 10.4 Kemin
  • 10.4.1 Business Overview
  • 10.4.2 Financial Data
  • 10.4.3 Concentrations Landscape
  • 10.4.4 Strategic Outlook
  • 10.4.5 SWOT Analysis
• 10.5 Tianjin Pharmaland Technology
  • 10.5.1 Business Overview
  • 10.5.2 Financial Data
  • 10.5.3 Concentrations Landscape
  • 10.5.4 Strategic Outlook
  • 10.5.5 SWOT Analysis
• 10.6 American River Nutrition, Inc
  • 10.6.1 Business Overview
  • 10.6.2 Financial Data
  • 10.6.3 Concentrations Landscape
  • 10.6.4 Strategic Outlook
  • 10.6.5 SWOT Analysis
• 10.7 Archer Daniels Midland Company
  • 10.7.1 Business Overview
  • 10.7.2 Financial Data
  • 10.7.3 Concentrations Landscape
  • 10.7.4 Strategic Outlook
  • 10.7.5 SWOT Analysis
• 10.8 Vitae Naturals
  • 10.8.1 Business Overview
  • 10.8.2 Financial Data
  • 10.8.3 Concentrations Landscape
  • 10.8.4 Strategic Outlook
  • 10.8.5 SWOT Analysis
• 10.9 Davos life Science
  • 10.9.1 Business Overview
  • 10.9.2 Financial Data
  • 10.9.3 Concentrations Landscape
  • 10.9.4 Strategic Outlook
  • 10.9.5 SWOT Analysis
• 10.10 Cargil
  • 10.10.1 Business Overview
  • 10.10.2 Financial Data
  • 10.10.3 Concentrations Landscape
  • 10.10.4 Strategic Outlook
  • 10.10.5 SWOT Analysis
• 10.11 Wilmer Spring Fruit Nutrition Products Co. Ltd
  • 10.11.1 Business Overview
  • 10.11.2 Financial Data
  • 10.11.3 Concentrations Landscape
  • 10.11.4 Strategic Outlook
  • 10.11.5 SWOT Analysis
• 10.12 FMC corporation
  • 10.12.1 Business Overview
  • 10.12.2 Financial Data
  • 10.12.3 Concentrations Landscape
  • 10.12.4 Strategic Outlook
  • 10.12.5 SWOT Analysis
• 10.13 Vidya Europe SAS
  • 10.13.1 Business Overview
  • 10.13.2 Financial Data
  • 10.13.3 Concentrations Landscape
  • 10.13.4 Strategic Outlook
  • 10.13.5 SWOT Analysis

Chapter 11 Potential Customer Profiles

• 11.1 Amway
  • 11.1.1 Business Overview
  • 11.1.2 Financial Data
  • 11.1.3 Concentrations Landscape
  • 11.1.4 Strategic Outlook
• 11.2 Solgar
  • 11.2.1 Business Overview
  • 11.2.2 Financial Data
  • 11.2.3 Concentrations Landscape
  • 11.2.4 Strategic Outlook
• 11.3 Life extension
  • 11.3.1 Business Overview
  • 11.3.2 Financial Data
  • 11.3.3 Concentrations Landscape
  • 11.3.4 Strategic Outlook
• 11.4 Jarrow Formulas
  • 11.4.1 Business Overview
  • 11.4.2 Financial Data
  • 11.4.3 Concentrations Landscape
  • 11.4.4 Strategic Outlook
• 11.5 NOW Foods
  • 11.5.1 Business Overview
  • 11.5.2 Financial Data
  • 11.5.3 Concentrations Landscape
  • 11.5.4 Strategic Outlook
• 11.6 Natures's Life
  • 11.6.1 Business Overview
  • 11.6.2 Financial Data
  • 11.6.3 Concentrations Landscape
  • 11.6.4 Strategic Outlook
• 11.7 Nutrovea
  • 11.7.1 Business Overview
  • 11.7.2 Financial Data
  • 11.7.3 Concentrations Landscape
  • 11.7.4 Strategic Outlook
• 11.8 Natures Lab
  • 11.8.1 Business Overview
  • 11.8.2 Financial Data
  • 11.8.3 Concentrations Landscape
  • 11.8.4 Strategic Outlook
• 11.9 Zenith Nutrition
  • 11.9.1 Business Overview
  • 11.9.2 Financial Data
  • 11.9.3 Concentrations Landscape
  • 11.9.4 Strategic Outlook
• 11.10 Blubonnet Nutrition
  • 11.10.1 Business Overview
  • 11.10.2 Financial Data
  • 11.10.3 Concentrations Landscape
  • 11.10.4 Strategic Outlook
• 11.11 Sirulina
  • 11.11.1 Business Overview
  • 11.11.2 Financial Data
  • 11.11.3 Concentrations Landscape
  • 11.11.4 Strategic Outlook
• 11.12 Caps Extra
  • 11.12.1 Business Overview
  • 11.12.2 Financial Data
  • 11.12.3 Concentrations Landscape
  • 11.12.4 Strategic Outlook
• 11.13 MacuShield
  • 11.13.1 Business Overview
  • 11.13.2 Financial Data
  • 11.13.3 Concentrations Landscape
  • 11.13.4 Strategic Outlook
• 11.14 PreserVision
  • 11.14.1 Business Overview
  • 11.14.2 Financial Data
  • 11.14.3 Concentrations Landscape
  • 11.14.4 Strategic Outlook
• 11.15 Efalex
  • 11.15.1 Business Overview
  • 11.15.2 Financial Data
  • 11.15.3 Concentrations Landscape
  • 11.15.4 Strategic Outlook
• 11.16 BioCare NutriGuard
  • 11.16.1 Business Overview
  • 11.16.2 Financial Data
  • 11.16.3 Concentrations Landscape
  • 11.16.4 Strategic Outlook
• 11.17 Futurebiotics
  • 11.17.1 Business Overview
  • 11.17.2 Financial Data
  • 11.17.3 Concentrations Landscape
  • 11.17.4 Strategic Outlook
• 11.18 Swanson Products
  • 11.18.1 Business Overview
  • 11.18.2 Financial Data
  • 11.18.3 Concentrations Landscape
  • 11.18.4 Strategic Outlook
• 11.19 Davis Vision
  • 11.19.1 Business Overview
  • 11.19.2 Financial Data
  • 11.19.3 Concentrations Landscape
  • 11.19.4 Strategic Outlook
• 11.20 Alcon
  • 11.20.1 Business Overview
  • 11.20.2 Financial Data
  • 11.20.3 Concentrations Landscape
  • 11.20.4 Strategic Outlook
• 11.21 Pfizer Inc.
  • 11.21.1 Business Overview
  • 11.21.2 Financial Data
  • 11.21.3 Concentrations Landscape
  • 11.21.4 Strategic Outlook
• 11.22 Vitabiotics Ltd.
  • 11.22.1 Business Overview
  • 11.22.2 Financial Data
  • 11.22.3 Concentrations Landscape
  • 11.22.4 Strategic Outlook
• 11.23 Valeant Pharmaceuticals International Inc.
  • 11.23.1 Business Overview
  • 11.23.2 Financial Data
  • 11.23.3 Concentrations Landscape
  • 11.23.4 Strategic Outlook
• 11.24 Alliance Pharma
  • 11.24.1 Business Overview
  • 11.24.2 Financial Data
  • 11.24.3 Concentrations Landscape
  • 11.24.4 Strategic Outlook
• 11.25 The Nature's Bounty Co
  • 11.25.1 Business Overview
  • 11.25.2 Financial Data
  • 11.25.3 Concentrations Landscape
  • 11.25.4 Strategic Outlook
• 11.26 Novartis AG
  • 11.26.1 Business Overview
  • 11.26.2 Financial Data
  • 11.26.3 Concentrations Landscape
  • 11.26.4 Strategic Outlook

관련자료